Signet Healthcare Partners Provides Growth Equity to Ascendia Pharmaceuticals

April 8, 2021

Signet Healthcare Partners, a New York-based growth equity firm, has made a growth equity investment in Ascendia Pharmaceuticals, a North Brunswick, New Jersey-based specialty CDMO. The proceeds will fund Ascendia's facility expansion and increased manufacturing capacity; Signet principals James Gale and Dr. Theron Odlaug will join Ascendia's board.

Buyers
Signet Healthcare Partners
Targets
Ascendia Pharmaceuticals, Inc.
Industry
Pharmaceuticals
Location
New Jersey, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.